Literature DB >> 8497374

Lifelong menstrual pattern and risk of breast cancer.

F Parazzini1, C La Vecchia, E Negri, S Franceschi, L Tozzi.   

Abstract

The relationship between lifelong menstrual pattern and the risk of breast cancer has been analyzed using data from a large case-control study conducted since 1983 in the greater Milan area including 3,037 cases, aged 74 years or less, with histologically confirmed breast cancer and 2,569 control subjects admitted for acute nongynecological, nonneoplastic nonhormone-related conditions to the same network of hospitals where cases had been identified. Compared with women reporting lifelong regular cycles, those reporting irregularities were at significantly reduced risk of breast cancer, relative risk estimate being 0.6, with 95% confidence interval (CI) ranging from 0.5 to 0.8. This protection was restricted to women reporting totally irregular menstrual cycles; compared to women reporting menstrual cycles lasting 25 days or less, the estimated relative risks were 1.0 and 1.2 in those reporting cycles lasting 26-30 days or 31 days or more, respectively, but 0.6 (95% CI 0.5-0.8) for those reporting totally irregular cycles. The effect of irregular menstrual cycles was similar in different strata of age and main risk factors for breast cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497374     DOI: 10.1159/000227183

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  12 in total

1.  Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women.

Authors:  F Clavel-Chapelon
Journal:  Cancer Causes Control       Date:  2002-11       Impact factor: 2.506

2.  A case-control study of menstrual factors in relation to breast cancer risk in African-American women.

Authors:  Jessica S B Beiler; Kangmin Zhu; Sandra Hunter; Kathleen Payne-Wilks; Chanel L Roland; Vernon M Chinchilli
Journal:  J Natl Med Assoc       Date:  2003-10       Impact factor: 1.798

3.  Fertility drugs and the risk of breast and gynecologic cancers.

Authors:  Louise A Brinton; Vikrant V Sahasrabuddhe; Bert Scoccia
Journal:  Semin Reprod Med       Date:  2012-04-27       Impact factor: 1.303

4.  Menstrual cycle characteristics and incidence of premenopausal breast cancer.

Authors:  Kathryn L Terry; Walter C Willett; Janet W Rich-Edwards; David J Hunter; Karin B Michels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-06       Impact factor: 4.254

5.  The utility of menstrual cycle length as an indicator of cumulative hormonal exposure.

Authors:  Sunni L Mumford; Anne Z Steiner; Anna Z Pollack; Neil J Perkins; Amanda C Filiberto; Paul S Albert; Donald R Mattison; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2012-07-26       Impact factor: 5.958

6.  Glycoprotein components in the serum of patients with cancer breast.

Authors:  M Varkey; R S Devi; S B Rao
Journal:  Indian J Clin Biochem       Date:  1997-12

7.  Long-term relationship of ovulation-stimulating drugs to breast cancer risk.

Authors:  Louise A Brinton; Bert Scoccia; Kamran S Moghissi; Carolyn L Westhoff; Shelley Niwa; David Ruggieri; Britton Trabert; Emmet J Lamb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04       Impact factor: 4.254

8.  Regularity and length of menstrual cycles in women aged 41-46 in relation to breast cancer risk: results from the DOM-project.

Authors:  I den Tonkelaar; F de Waard
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study.

Authors:  B Tehard; R Kaaks; F Clavel-Chapelon
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

Review 10.  Circulatory estrogen level protects against breast cancer in obese women.

Authors:  Zsuzsanna Suba
Journal:  Recent Pat Anticancer Drug Discov       Date:  2013-05       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.